Cerebral ischemia-induced angiogenesis is dependent on tumor necrosis factor receptor 1-mediated upregulation of α5β1 and αVβ3 integrins

Heng Huang, Qijuan Huang, Fuxin Wang, Richard Milner, Longxuan LiJournal of Neuroinflammation 2016 · DOI

Abstract

Our results suggest that TNFR1-mediated signaling plays a critical role in triggering angiogenic integrins and subsequent angiogenic responses following cerebral ischemia. These novel findings could form a platform for future therapeutic strategies aimed at stimulating angiogenesis following cerebral ischemia.

Introduction: The Challenge of Post-Stroke Repair

Following a cerebral ischemic stroke, the brain initiates a repair process known as angiogenesis—the formation of new blood vessels. This response is particularly vital in the "ischemic penumbra," the salvageable tissue surrounding the stroke's core. Increased vessel density in this region is strongly associated with improved patient survival and functional recovery.

While the cytokine Tumor Necrosis Factor-alpha (TNF-α) is a known mediator of injury response, its specific role in post-stroke angiogenesis has remained controversial. TNF-α signals through two receptors: TNFR1, typically linked to cell death, and TNFR2, linked to survival. This study investigates which receptor drives vascular remodeling and identifies the molecular "anchors" (integrins) required for this process.

Methodology

The researchers utilized a multi-faceted approach combining animal models and cell cultures:

  • In Vivo Models: C57BL6 mice underwent a 90-minute middle cerebral artery occlusion (MCAO) to simulate stroke.
  • Targeted Inhibition: Neutralizing antibodies against TNFR1 or TNFR2 were administered via daily brain injections for four days post-stroke.
  • Vascular Analysis: Immunofluorescence tracking CD31 (vessels) and Ki67 (proliferation) was performed at 4, 7, and 14 days.
  • In Vitro Analysis: Human brain microvascular endothelial cells (HBMECs) were treated with TNF-α to observe effects on growth and integrin expression (α5, β1, αV, and β3) via flow cytometry.

TNFR1 as a Driver of Angiogenesis

Contrary to its common association with apoptosis, TNFR1 was found to be the essential trigger for post-stroke angiogenesis. Experimental results showed that blocking TNFR1 significantly reduced blood vessel density in the ischemic penumbra, whereas blocking TNFR2 had no significant effect.

Figure 1: Pharmacological blockade of TNFR1, but not TNFR2, reduced the angiogenic response in the cerebral ischemic penumbra. (a) CD31 staining of vessels. (b) Quantification of CD31+ vessels over 14 days.

As shown in the figure above, the reduction in vessel density was dose-dependent for anti-TNFR1 antibodies (50–100 ng/day). This effect was most pronounced at the 14-day mark, highlighting the receptor's role in sustained vascular repair.

The Role of Integrins: Molecular "Glue"

The study identified a critical link between TNFR1 signaling and the upregulation of α5β1 and αVβ3 integrins. These proteins are essential for endothelial cells to adhere to the extracellular matrix, allowing them to proliferate and migrate.

Key findings regarding this pathway include:

  • Synchronized Response: The surge in integrin expression matches the peak of endothelial cell proliferation around day 7 post-stroke.
  • Functional Necessity: Directly blocking these integrins inhibited the growth-promoting effects of TNF-α, confirming they are necessary downstream components of the TNFR1 pathway.
  • Organ Specificity: Unlike other tissues (such as hindlimb ischemia) where TNFR2 may dominate angiogenesis, the brain's repair mechanism appears uniquely dependent on TNFR1.

Conclusion and Future Directions

This research clarifies the role of TNF-α in the brain, positioning TNFR1 as a key mediator of repair rather than just a "death receptor." However, several challenges remain for clinical application:

  • The Signaling Paradox: Because TNFR1 also mediates apoptosis, therapeutic strategies must find ways to selectively activate angiogenic pathways without triggering cell death.
  • Functional Recovery: Future studies are needed to determine if this TNFR1-mediated angiogenesis translates into improved long-term behavioral and motor recovery.
  • Clinical Translation: Further investigation is required to see if these pathways remain consistent in older populations with common stroke comorbidities like hypertension or diabetes.

Summary updated

Abstract

Our results suggest that TNFR1-mediated signaling plays a critical role in triggering angiogenic integrins and subsequent angiogenic responses following cerebral ischemia. These novel findings could form a platform for future therapeutic strategies aimed at stimulating angiogenesis following cerebral ischemia.
BibTeX
@article{huang2016cerebral,
  author = {Heng Huang and Qijuan Huang and Fuxin Wang and Richard Milner and Longxuan Li},
  title = {{Cerebral ischemia-induced angiogenesis is dependent on tumor necrosis factor receptor 1-mediated upregulation of α5β1 and αVβ3 integrins}},
  journal = {Journal of Neuroinflammation},
  year = {2016},
  doi = {10.1186/s12974-016-0697-1},
}
Figure